Sahel General Hospital Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2010
NCT01041911
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Sahel Teaching Hospital, General Committee of teaching Hospitals and Institutes | Sahil Hospital, Tawdw Niwas, 1st Floor Khopat, Thane

Active Ingredients

Drugs in Phase 3 Trials (1)

allogeneic mesenchymal stem cells (1 trial)

Drugs in Phase 2 Trials (3)

docetaxel (taxotere) (1 trial)

euphorbia (1 trial)

vinorelbine (navelbine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 1 (Phase 3)

Hemorrhoids (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4